Scribe Therapeutics Inc.

US$15.70As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SCTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$297.2M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$18
17.49%
(45.72%)
Hold 11|8|7|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.22
0.22
0.22
0.23
16.62%
6.87%
8.71%
4.39%
Revenue$M
33.19
33.11
32.93
32.31
2.25%
3.76%
2.71%
(2.40%)
Peers (US$297.2M)
Cap (US$)
PE
297.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.934
(0.025)
(0.025)
EBIT/Intx
9.335
0.053
0.050
Own earn%
(326.23)
14.98
17.37
Sh yield%
50.50
33.73
34.29
Owners
Insiders/Inst%
4.15
56.15
Short interest%
3.44
SBC / revenue%
5.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
11–15
$1 testx
−0.1
Incr. ROIC%
6